Hayfin Capital Management

Hayfin Capital Management, established in 2009 and headquartered in London, is an independent investment firm specializing in providing lending solutions and asset management services primarily to European middle-market companies and institutional clients. The firm operates with a focus on four key debt investment strategies: direct lending, special opportunities, tactical credit, and high-yield credit. Hayfin seeks to deliver strong risk-adjusted returns by leveraging its expertise in managing complex restructurings and workouts, supported by a diverse team skilled in various sectors such as healthcare, shipping, and real estate. With a commitment to local market presence, Hayfin has expanded its operations across major European cities, including Amsterdam, Frankfurt, Madrid, Paris, and Luxembourg, and has recently begun establishing a growing footprint in the United States with an office in New York. The firm emphasizes the importance of insightful analysis and disciplined investing, aiming to recruit and retain top industry talent to drive its success.

Richard Baxter

Managing Director, Healthcare

Atin Dhawan

Investment Analyst

Timothy Flynn

CEO

Olaf Hartmann

Portfolio Manager and Managing Director

Jeff Sockwell

Managing Director, Origination

Mark Tognolini

Co-Founder, COO and Member, Management Committee

10 past transactions

KEO World

Venture Round in 2022
Provider of all-digital inventory financing and payment services intended to offer loans for businesses and consumers. The company's platform uses artificial intelligence and machine learning to anonymously open banking transactional data, thus offering potential customers maximum funding in seconds, enabling individuals to have access to instant funds.

ADMA Biologics

Post in 2022
ADMA Biologics, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics aimed at treating immune deficiencies and infectious diseases in the United States. The company's product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin products indicated for primary humoral immunodeficiency, as well as Nabi-HB, which treats acute exposure to Hepatitis B. ADMA also has a pipeline of therapeutics targeting infections such as S. pneumonia. To support its production, ADMA operates FDA-licensed source plasma collection facilities, known as ADMA BioCenters, which supply plasma for its products. The company distributes its offerings through independent distributors, sales agents, and specialty pharmacies. Founded in 2004 and headquartered in Ramsey, New Jersey, ADMA Biologics is dedicated to serving niche patient populations, particularly those who are immune-compromised due to underlying conditions or medical treatments.

KEO World

Debt Financing in 2022
Provider of all-digital inventory financing and payment services intended to offer loans for businesses and consumers. The company's platform uses artificial intelligence and machine learning to anonymously open banking transactional data, thus offering potential customers maximum funding in seconds, enabling individuals to have access to instant funds.

Avadim Health

Acquisition in 2021
Avadim Health, Inc. is a healthcare and wellness company based in Asheville, North Carolina, that specializes in developing, manufacturing, and marketing topical products for both institutional care and consumer markets. Utilizing its proprietary Bionome Engineered Platform, Avadim Health creates solutions aimed at enhancing immune health, neuromuscular health, and skin barrier health. Its product portfolio addresses various health issues, including pain, infections, muscle cramps and spasms, restless leg symptoms, and joint discomfort. The company distributes its products through retail outlets such as grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and other long-term care facilities. Additionally, Avadim Health offers its products online, providing accessible solutions for patients seeking to manage healthcare-associated risks. Founded in 2007, the company was previously known as Avadim Technologies Inc. before changing its name in September 2018.

Amicus Therapeutics

Post in 2020
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Mimedx

Post in 2020
MiMedx Group, Inc. is a biopharmaceutical company that specializes in developing and marketing regenerative biologics using human placental tissue allografts. The company employs a proprietary processing method known as the PURION Process, which utilizes aseptic techniques and terminal sterilization to create its allografts. MiMedx offers a range of biomaterial technologies, including EpiFix and AmnioFix, which are utilized in treating chronic wounds and surgical procedures, respectively. Other notable products include EpiCord and AmnioCord, which serve as connective tissue matrices, and AmnioFill, designed to enhance healing. The company's offerings cater to various medical fields, including wound care, orthopedics, sports medicine, ophthalmology, and dentistry. MiMedx sells its products through a combination of direct sales, independent agents, and distributors in the United States and internationally. Headquartered in Marietta, Georgia, MiMedx Group has been operational since February 2008.

GC Aesthetics

Venture Round in 2018
GC Aesthetics is a privately held company based in Dublin, Ireland, specializing in the development and manufacturing of silicone breast implants and related medical devices for the female aesthetics market. The company offers a variety of surgical implants and tissue expanders, providing surgeons with options for breast augmentation, aesthetic enhancement, and reconstructive procedures. In addition to breast implants, GC Aesthetics produces silicone products for scar management, such as Silgel, which helps reduce the appearance of scars. The company also provides patient support tools to facilitate informed decision-making about surgical options, as well as a program to assist physicians in generating patient interest. With a presence in 90 countries, including regions in Europe, Asia, and South America, GC Aesthetics has established a significant international footprint since its incorporation in 2015. Its manufacturing facilities are located in Scotland, England, and France.

Avadim Health

Debt Financing in 2018
Avadim Health, Inc. is a healthcare and wellness company based in Asheville, North Carolina, that specializes in developing, manufacturing, and marketing topical products for both institutional care and consumer markets. Utilizing its proprietary Bionome Engineered Platform, Avadim Health creates solutions aimed at enhancing immune health, neuromuscular health, and skin barrier health. Its product portfolio addresses various health issues, including pain, infections, muscle cramps and spasms, restless leg symptoms, and joint discomfort. The company distributes its products through retail outlets such as grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and other long-term care facilities. Additionally, Avadim Health offers its products online, providing accessible solutions for patients seeking to manage healthcare-associated risks. Founded in 2007, the company was previously known as Avadim Technologies Inc. before changing its name in September 2018.

Kingsland Capital

Acquisition in 2017
is an employee owned investment manager. It provides its services to Funds and collateralised loan obligations. The firm invests in the fixed income markets. It invests in corporate debt securities, high yield bonds, distressed assets, leveraged loans, and other types of investments. The firm employs fundamental and technical analysis to create its portfolios.

NKD

Debt Financing in 2015
NKD Group is a retail business that specializes in offering a wide range of textiles and home accessories. The company provides fashionable clothing options for men, women, and children, catering to diverse tastes and preferences. Customers can find a variety of items, including dresses, blouses, trousers, and jackets at competitive prices. Additionally, NKD features functional sportswear and home textiles, as well as seasonal decorations. The product assortment is available through both online and offline stores, ensuring accessibility and convenience for shoppers. By regularly updating its offerings with seasonal novelties and trends, NKD aims to meet the evolving needs of residential households and the sports sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.